Caricamento...

Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity

The safety and feasibility of dendritic cell (DC)-based immunotherapies in cancer management have been well documented after more than twenty-five years of experimentation, and, by now, undeniably accepted. On the other hand, it is equally evident that DC-based vaccination as monotherapy did not ach...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pharmaceutics
Autori principali: Lamberti, María Julia, Nigro, Annunziata, Mentucci, Fátima María, Rumie Vittar, Natalia Belén, Casolaro, Vincenzo, Dal Col, Jessica
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7151083/
https://ncbi.nlm.nih.gov/pubmed/32178288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12030256
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !